Sergey Leshkov is an entrepreneur, investor, and co‐owner of several companies, which work in the areas of biotechnology, creating new medicines and medical technology.
In 2000, he co‐founded Ekomir, a manufacturer of modern nutraceuticals. According to the 2006‐2012 figures, the company was in the top ten leading manufacturers of dietary supplements on the Russian pharmaceutical market. In June of 2013, it was acquired by a Canadian company, Valeant Pharmaceuticals International, Inc.
In 2005, Mr. Leshkov co‐founded (since 2012 – Premium Aesthetics), one of the leading Russian distributors of medical technology in the field of aesthetic medicine. Premium Aesthetics is the exclusive distributor of such worldwide known manufacturers as Solta Medical, Zeltiq (USA), and Lumenis (Israel) in the Russian Federation and other parts of the former Soviet Union. The company has been repeatedly named “Best Distributor of the Year in the EMEA region” by its partners.
Mr. Leshkov is also a co‐founder of several companies, dedicated to the creation of new drugs in the fields of diabetes, oncology, and hepatitis C therapies. Two of them are resident companies of the Skolkovo Foundation.
He is also an investor in various biotech companies in the USA and Switzerland. He serves on the board of directors for CardioCell (USA) and Stemedica International (Switzerland).
Mr. Leshkov is a graduate of the Moscow Academy for Humanities and Social Studies (formerly Moscow Humanitarian University) with a Degree in Psychology.